1. Home
  2. FNKO vs ACOG Comparison

FNKO vs ACOG Comparison

Compare FNKO & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Funko Inc.

FNKO

Funko Inc.

HOLD

Current Price

$3.18

Market Cap

157.1M

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$5.99

Market Cap

130.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNKO
ACOG
Founded
2017
2000
Country
United States
Canada
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
157.1M
130.9M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
FNKO
ACOG
Price
$3.18
$5.99
Analyst Decision
Buy
Strong Buy
Analyst Count
4
1
Target Price
$7.13
$18.00
AVG Volume (30 Days)
1.2M
96.0K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$928,842,000.00
$7,427,199.00
Revenue This Year
N/A
N/A
Revenue Next Year
$10.57
$101.16
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.22
$3.75
52 Week High
$14.65
$11.54

Technical Indicators

Market Signals
Indicator
FNKO
ACOG
Relative Strength Index (RSI) 50.88 47.68
Support Level $2.72 $5.66
Resistance Level $3.09 $6.20
Average True Range (ATR) 0.24 0.47
MACD -0.01 0.08
Stochastic Oscillator 32.96 69.59

Price Performance

Historical Comparison
FNKO
ACOG

About FNKO Funko Inc.

Funko Inc is an USA based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: